Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma. - Vigipallia

0 avis

Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma.

Archive ouverte

Salas, S. | Ciccolini, J. | Pourroy, B. | Fanciullino, R. | Tranchand, B. | Monjanel-Mouterde, S. | Baciuchka-Palmaro, M. | Dupuis, C. | Yang, C. | Balti, M. | Lacarelle, B. | Duffaud, F. | Durand, A. | Favre, R. | Mercier, Cédric

Edité par CCSD ; Lippincott, Williams & Wilkins -

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Dose individualization of carboplatin after a 120-hour infusion schedule: higher dose intensity but fewer toxicities

Archive ouverte | Mercier, Cédric | CCSD

High incidence of CDA deficiency in patients with hematological malignancies: perspectives and therapeutic implications

Archive ouverte | Donnette, M. | CCSD

International audience

Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen

Archive ouverte | Farnault, L. | CCSD

International audience

Chargement des enrichissements...